
Dr. Kunal Mahajan
@kunalmahajan4
MD, DM, FACC, FESC, FSCAI, FAPSC, FAPSIC
Director and Chief Interventional Cardiologist,
Himachal Heart Institute, Mandi, HP, India
ID: 393831703
http://drkunalmahajan.com 19-10-2011 04:25:40
548 Tweet
508 Followers
291 Following

Must read for all Indian physicians. Congratulations Lipid Association of India





✨ What an INCREDIBLE experience meeting the amazing Dr. Purvi Parwani ! 🌟 Her inspiring personality and passion for her work truly light up the room. 💫 Feel so grateful to have crossed paths with such a remarkable individual! #Inspiration #WomenInLeadership #MeetTheTrailblazer







Early initiation of SGLT2 inhibitors like Dapagliflozin & Empagliflozin in ACUTE MYOCARDIAL INFARCTION (HEART ATTACK) is safe, well tolerated & is associated with reduction in the need for hospitalisation with heart failure touchendocrinology.com/diabetes/journ… Dr ABM Kamrul Hasan Dr. Kunal Mahajan



"A simple change in treatment guidelines could have a huge impact on patients". — Prof Kausik Ray FMedSci Prescribing statins and ezetimibe after a heart attack can help lower the risk of a second heart attack or stroke. 🫀 More in The Guardian ⤵️ Imperial School of Public Health theguardian.com/science/2025/a…

Apo b is always good . Today,we only reduce apob through ldl . We donot have apob lowering drugs for clinical lipidology. So,ldl is a compulsion. Dr. Kunal Mahajan Lipid Association of India MIЯVΛƬ #IC ༄ 。° Pablo Corral MD S Nagendra Boopathy SABOURETCardiologist Sam Tsimikas, MD
